Cargando…

INTERFERing with the progression of T-cell acute lymphoblastic leukemia: a multifaceted therapy

Detalles Bibliográficos
Autor principal:	Herranz, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152966/ https://www.ncbi.nlm.nih.gov/pubmed/34647445 http://dx.doi.org/10.3324/haematol.2021.279549

Ejemplares similares

Central nervous system therapy in acute lymphoblastic leukemia: no more, no less
por: Rives, Susana
Publicado: (2023)

The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia
por: Zhou, Yun, et al.
Publicado: (2020)

Towards personalized chemotherapy of acute lymphoblastic leukemia
por: Hnízda, Aleš, et al.
Publicado: (2018)

Under the surface: scratching the acute lymphoblastic leukemia niche
por: Gower, Mark, et al.
Publicado: (2022)

A Child with Acute Lymphoblastic Leukemia in Institutional Isolation during the COVID Pandemic: A Multifaceted Responsibility
por: Rathore, Puneet, et al.
Publicado: (2020)

Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia
por: Minieri, Valentina, et al.
Publicado: (2018)

Zebrafish MYC-induced leukemia models: unique in vivo systems to study B and T cell acute lymphoblastic leukemia
por: Borga, Chiara, et al.
Publicado: (2019)

Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
por: Conter, Valentino, et al.
Publicado: (2021)

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
por: García-Cañaveras, Juan C., et al.
Publicado: (2020)

Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matter
por: Ribera, Josep-Maria
Publicado: (2021)

On the hunt for B-cell lymphoblastic leukemia-initiating stem cells
por: Wojcik, Bartosch, et al.
Publicado: (2017)

Slowly progressing acute lymphoblastic leukemia with prolonged leukopenia
por: Sugisaki, Manato, et al.
Publicado: (2023)

Obesity and height in children and adolescents with acute lymphoblastic leukemia and its future management
por: Browne, Emily K., et al.
Publicado: (2019)

Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab
por: Hladnik,1, Lindsay, et al.
Publicado: (2016)

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019)

Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)

Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2021)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017)

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2015)

A chemotherapy-free regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia: are we there yet?
por: Ofran, Yishai
Publicado: (2021)

Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression
por: Tsaouli, Georgia, et al.
Publicado: (2019)

Progress in Treatment of Viral Infections in Children with Acute Lymphoblastic Leukemia
por: Moschovi, Maria, et al.
Publicado: (2016)

The progress in the relationship between trace elements and acute lymphoblastic leukemia
por: Wang, Jing, et al.
Publicado: (2023)

N-Me, a long range oncogenic enhancer in T-cell acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2014)

How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?
por: Pinchinat, Ashley, et al.
Publicado: (2022)

Improving the treatment of childhood acute lymphoblastic leukemia by optimizing the use of 70-year-old drugs
por: Evans, William E.
Publicado: (2021)

Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
por: Stutterheim, Janine, et al.
Publicado: (2021)

Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: history, current situation, and future
por: Muller, Bradley J., et al.
Publicado: (2023)

Recent updates for antibody therapy for acute lymphoblastic leukemia
por: Li, Le, et al.
Publicado: (2020)

The Multifaceted Roles for NRF2 in Regulating Tumor Development and Progression: An Update
por: Kim, Su-Jung, et al.
Publicado: (2023)

Targeting the bone marrow microenvironment: a novel therapeutic strategy for pre-B acute lymphoblastic leukemia
por: Kotecha, Rishi S., et al.
Publicado: (2019)

A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia
por: Puri, Pranav, et al.
Publicado: (2020)

Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia
por: Ebinger, Sarah, et al.
Publicado: (2016)

Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia
por: Sugita, Mayumi, et al.
Publicado: (2023)

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
por: Shimony, Shai, et al.
Publicado: (2022)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
por: Cooper, Todd M
Publicado: (2007)

A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
por: Shikdar, Sufana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9vppq5ut654dskthd11df2n935